Emergent BioSolutions to Release Second Quarter 2017 Financial Results and Conduct a Conference Call on August 3, 2017
July 20, 2017 07:00 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., July 20, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will release its second quarter financial results immediately after market close on Thursday, August 3,...
Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 25, 2017 at 9:00 AM EDT; Webcast Will be Available
May 11, 2017 07:00 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., May 11, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 25, 2017 beginning at...
Emergent BioSolutions to Release First Quarter 2017 Financial Results and Conduct a Conference Call on May 4, 2017
April 20, 2017 07:00 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., April 20, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, May 4, 2017 at 5:00 pm (Eastern Time) to discuss the financial...
Emergent BioSolutions Reports Third Quarter and Nine Months 2016 Financial Results
November 07, 2016 16:15 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and nine months ended September 30, 2016. FINANCIAL...
Emergent BioSolutions to Release Third Quarter 2016 Financial Results and Conduct a Conference Call on November 7, 2016
November 01, 2016 07:00 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will release its financial results for the third quarter on Monday, November 7, 2016 and host a...
Emergent BioSolutions Awarded BARDA Contract for Advanced Development and Delivery of NuThrax, a Next Generation Anthrax Vaccine, Valued at Up to $1.6 Billion
September 30, 2016 09:04 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., Sept. 30, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a multi-year contract with the Biomedical Advanced Research and...
SHAREHOLDER ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 Deadline in Class Action - EBS
August 31, 2016 15:51 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 31, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Emergent BioSolutions, Inc. common stock (NYSE:EBS) from January 11, 2016...
Emergent BioSolutions Reports Second Quarter and Six Months 2016 Financial Results
August 04, 2016 16:15 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and six months ended June 30, 2016. FINANCIAL HIGHLIGHTS ...
Emergent BioSolutions to Release First Quarter 2016 Financial Results and Conduct a Conference Call on May 5, 2016
April 21, 2016 16:15 ET
|
Emergent Biosolutions, Inc.
GAITHERSBURG, Md., April 21, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, May 5, 2016 at 5:00 pm (Eastern Time) to discuss the...
Emergent BioSolutions to Participate in Needham & Company’s 15th Annual Healthcare Conference in April 2016
March 30, 2016 07:01 ET
|
Emergent Biosolutions, Inc.
GAITHERSBURG, Md., March 30, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will participate in Needham...